Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.
The global nuclear medicine market is expected to grow from $6.00 billion in 2021 to $6.77 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The nuclear medicine market is expected to grow to $11.20 billion in 2026 at a CAGR of 13.4%.
The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person's distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users.
North America was the largest region in the nuclear medicine market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this nuclear medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The increasing constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy.
As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market. For instance, in 2020, according to GLOBOCAN, a US-based cancer observatory, there were 19.29k new cancer cases in the world in the year 2020, and 28.88k cases are anticipated by 2040. Further, in 2019, according to the World Health Organization (WHO), a Switzerland-based international organisation responsible for public health, estimates that 17.9 million people worldwide died from cardiovascular diseases (CVDs) in the year 2019, accounting for 32% of all fatalities. 85% of these fatalities were caused by heart attack and stroke. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine market.
Product innovation is the key trend gaining popularity in the nuclear medicine market. Major companies operating in the nuclear medicine market are focused on developing new innovative products to strengthen their position.
For instance, in March 2021, GE Healthcare, a US-based company that deals with nuclear medicine, launched Star Guide, a new nuclear medicine system to assist in advancing precision health and theranostics. StarGuide uses the most recent developments in Cadmium Zinc Telluride (CZT) technology to assist providers in exploring and better understanding the patient's condition, enhancing patient outcomes throughout the continuum of care. It has unique features such as digital focus detectors and 360-degree imaging of the system that are intended to support improved theranostic capabilities in nuclear medicine and advanced precision health.
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value (USD) in 2022 | $6.77 billion |
| Forecasted Market Value (USD) by 2026 | $11.2 billion |
| Compound Annual Growth Rate | 13.4% |
| Regions Covered | Global |
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Assessment of Russia - War Impact on agriculture, energy and mineral commodities supply and their direct and indirect impact on the market analyzed in the report.
- Impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- All data from the report will also be delivered in an excel format.
Scope
Markets Covered:
1) By Type: Diagnostic; Therapeutic
2) By Application: Cardiology; Lymphomia; Thyroid; Neurology; Oncology; Other Application
3) By End-User: Hospitals and Clinics; Diagnostic Centers; Other End Users
Key Topics Covered:
1. Executive Summary
2. Nuclear Medicine Market Characteristics
3. Nuclear Medicine Market Trends And Strategies
4. Nuclear Medicine Market - Macro Economic Scenario
5. Nuclear Medicine Market Size And Growth
6. Nuclear Medicine Market Segmentation
7. Nuclear Medicine Market Regional And Country Analysis
8. Asia-Pacific Nuclear Medicine Market
9. China Nuclear Medicine Market
10. India Nuclear Medicine Market
11. Japan Nuclear Medicine Market
12. Australia Nuclear Medicine Market
13. Indonesia Nuclear Medicine Market
14. South Korea Nuclear Medicine Market
15. Western Europe Nuclear Medicine Market
16. UK Nuclear Medicine Market
17. Germany Nuclear Medicine Market
18. France Nuclear Medicine Market
19. Eastern Europe Nuclear Medicine Market
20. Russia Nuclear Medicine Market
21. North America Nuclear Medicine Market
22. USA Nuclear Medicine Market
23. South America Nuclear Medicine Market
24. Brazil Nuclear Medicine Market
25. Middle East Nuclear Medicine Market
26. Africa Nuclear Medicine Market
27. Nuclear Medicine Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Nuclear Medicine Market
29. Nuclear Medicine Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
- Bracco Imaging S.P.A.
- Lantheus Medical Imaging Inc.
- NTP Radioisotopes SOC Ltd
- Eckert & Ziegler Group
- Jubilant Pharma LLC
- Australian Nuclear Science & Technology Organization
- Cardinal Health Inc
- GE Healthcare
- Curium Pharma7
- Advanced Accelerator Applications
- Nordion Inc.
- The institute for radioelements
- Eczacibasi-Monrol
- Siemens Healthineers AG
- Cambridge Isotope Laboratories Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mb0gr9
Attachment
